Not Yet RecruitingNCT07310381
Vagus Nerve Stimulation (VNS) Electroencephalogram (EEG) Protocol Supplement
This study isn't recruiting yet.
Location not clearly listedDepressionDevice studyAges 18+
Depression studies
Depression
Depression involves persistent low mood or loss of interest, often with tiredness and changes in sleep or appetite.
TerminatedNCT06514742
Aticaprant 10 mg for depression
What is this study about?
This study evaluates the safety and effectiveness of Aticaprant for people with depression.
This study ended early.
Multiple locations, including HuntsvilleDepressionMedication studyAges 18–64
CompletedNCT05550532
Aticaprant 10 Milligrams (mg) for Depression
What is this study about?
This study evaluated the safety and effectiveness of Aticaprant for people with depression.
This study has finished and is no longer accepting participants.
Multiple locations, including BirminghamDepressionMedication studyAges 18–74
TerminatedNCT06635135
Aticaprant Plus an Antidepressant to Prevent Return of Depression Symptoms for depression
Official study title
A Randomized, Double-blind, Multicenter, Placebo-controlled Study of Adjunctive Aticaprant Plus an Antidepressant for Relapse Prevention in Major Depressive Disorder (MDD) With Moderate-to-severe Anhedonia
This study ended early.
Multiple locations, including Little RockDepressionMedication studyAges 18–64
TerminatedNCT00637494
Mifepristone for depression
What is this study about?
This study evaluates the safety and effectiveness of mifepristone for people with depression.
This study ended early.
Multiple locations, including Little RockDepression, SchizophreniaMedication studyAges 22+
CompletedNCT07212946
Ayahuasca and Esketamine for Major Depression
Official study title
Four Doses of Ayahuasca or Esketamine in Major Depressive Disorder: a Double-blind Randomized Trial
This study has finished and is no longer accepting participants.
In Ribeirão PretoDepressionMedication studyAges 18–65
RecruitingACTRN12619001037190
Cognitive-behavioral therapy for depressive symptoms in older adults living in residential aged care facilities: A cluster -controlled study in Australia
Official study title
In AustraliaELders AT Ease Program (ELATE): A cluster randomised controlled trial of a sustainable and scalable mental health service for Australian residential aged care facilities
Depression, AnxietyInterventional studyAges 18+
RecruitingACTRN12625000108415
Evaluating the acceptability of a therapist-assisted, online parenting program (‘PiP-TEx’) to support parents of adolescents who are experiencing anxious and/or depressive symptoms following a traumatic experience.
Official study title
In AustraliaAn open-label, uncontrolled acceptability trial of a therapist-assisted, online parenting program (‘PiP-Trauma Experience’) to support parents of adolescents who are experiencing anxious and/or depressive symptoms following a traumatic event.
DepressionInterventional studyAges 18+
RecruitingACTRN12624000017527
MELODY study: A 12-week controlled study of adjunctive melatonin or digital cognitive behavioural therapy for insomnia, or placebo to improve depressive symptoms in young adults with mood disorders
Official study title
In CamperdownMELODY Trial: A 12-week randomised controlled trial of adjunctive melatonin or digital cognitive behavioural therapy for insomnia, or placebo to improve depressive symptoms in young adults with mood disorders
Depression, BipolarityInterventional studyAges 18–30
RecruitingACTRN12614000979651
Reducing the impact of aphasia in stroke patients and their caregivers a year post onset via a brief early intervention: a cluster control study of the Aphasia Action Success Knowledge (ASK) program.
Official study title
In AustraliaReducing the psychosocial impact of aphasia on mood and quality of life in people with aphasia and the impact of caregiving in family members through the Aphasia Action Success Knowledge (Aphasia ASK) program: study protocol for a randomized controlled trial
DepressionInterventional studyAges 18+
TerminatedACTRN12618001953224
Magnetic Stimulation for treatment-resistant depression
Official study title
A New Zealand Neuroimaging Study of Repetitive Transcranial Magnetic Stimulation (rTMS) in Treatment-Resistant Depression as assessed by the Montgomery–Åsberg Depression Rating Scale.
This study ended early.
In New ZealandDepressionInterventional studyAges 18+
Active Not RecruitingNCT05849402
Accelerated Intermittent Theta-Burst Stimulation (aiTBS) in Treatment-Resistant Depression of Bipolarity type II
Official study title
Accelerated Intermittent Theta-Burst Stimulation (aiTBS) in Treatment-Resistant Depression of Bipolar II Disorder
This study is no longer accepting new participants.
In Palo AltoDepression, BipolarityDevice studyAges 18–80
Registry coverage
We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.